{"id":434482,"date":"2024-10-20T07:44:18","date_gmt":"2024-10-20T07:44:18","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-pd-iso-ts-233662023\/"},"modified":"2024-10-26T14:41:00","modified_gmt":"2024-10-26T14:41:00","slug":"bsi-pd-iso-ts-233662023","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-pd-iso-ts-233662023\/","title":{"rendered":"BSI PD ISO\/TS 23366:2023"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 4 Principle <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 5 Selection of fluorescent nanoparticles 5.1 General 5.2 Characteristics of nanoparticle <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 6 Quantification system 6.1 Overall design <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 6.2 Antibody 6.2.1 General 6.2.2 Antibody type 6.2.3 Target antigen <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 6.2.4 Applicability of antibody to method 6.2.5 Animal species 6.2.6 Immunoglobulin class 6.2.7 Titre <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 6.2.8 Specificity 6.3 Staining procedure 6.3.1 Staining conditions 6.3.2 Robustness of staining procedure <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 6.4 Image processing 6.4.1 Image quality and relevant factors 6.4.2 Selection of image processing software <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 7 Comparability of results 7.1 Light source adjustment 7.2 Reference material 8 Performance characteristics 8.1 Background 8.1.1 General <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 8.1.2 Autofluorescence 8.1.3 Nonspecific absorption of nanoparticles 8.1.4 Nonspecific absorption of antibodies 8.1.5 Loss of intensity and interferences <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 8.2 Reference material dependent indices 8.2.1 General 8.2.2 Limit of detection (LOD) 8.2.3 Limit of quantification (LOQ) 8.2.4 Linearity and dynamic range <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 8.3 Robustness 9 Validation and verification 9.1 General 9.2 Single lab precision <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 9.3 Reproducibility 10 Reporting <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | Annex A (informative) Example of the reference material <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | Annex B (informative) Example of the nanoparticle aggregation\/agglomeration evaluation method <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Nanotechnologies. Performance evaluation requirements for quantifying biomolecules using fluorescent nanoparticles in immunohistochemistry<\/b><\/p>\n |